Drug intelligence / Profile preview

CCN1

Development stage
Preclinical
Lead developer
University of Michigan
Modality
Recombinant Proteins and Enzymes
01

Overview

CCN1 (Cellular Communication Network Factor 1), also known as CYR61, is a matricellular protein that plays a critical role in tissue remodeling and wound healing. In the context of pulmonary fibrosis (PF), CCN1 is highly expressed by transitional alveolar epithelial cells. Research from the University of Michigan suggests that CCN1 acts as a protective "brake" on fibrotic remodeling by inducing apoptosis in these pathologic transitional cells, likely through the activation of a p53-dependent intrinsic apoptosis cascade and caspase-3. Recombinant CCN1 is being investigated as a potential therapeutic agent to limit the aberrant accumulation of transitional cells and improve clinical outcomes in patients with lung fibrosis.

Other names
CYR61CYR-61CYR 61Cellular communication network factor 1Cysteine-rich angiogenic inducer 61
02

Targets

SDC4 (Syndecan-4)α6β1 (Integrin alpha-6/beta-1 complex)αVβ3 (Integrin αVβ3)αVβ5 (Integrin αVβ5)

Beyond the preview

Go deeper on CCN1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CCN1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call